Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRB2 | P62993 | 3/20 | 0.86 |
| ▸ | MAPT | P10636 | 2/20 | 0.86 |
| ▸ | RECQL | P46063 | 2/20 | 0.86 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.86 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.86 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.86 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.86 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.86 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.86 |
| ▸ | CASP1 | P29466 | 1/20 | 0.86 |
| ▸ | HTT | P42858 | 1/20 | 0.86 |
| ▸ | BLM | P54132 | 1/20 | 0.86 |
| ▸ | CASP7 | P55210 | 1/20 | 0.86 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.86 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.86 |
| ▸ | DDR2 | Q16832 | 1/20 | 0.86 |
| ▸ | NGLY1 | Q96IV0 | 1/20 | 0.86 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.86 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.30 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17360642 | 1.00 | GRB2 (0.86) | GRB2MAPTRECQLSMN1; SMN2ABCB11 | |
| SCHEMBL29352907 | 1.00 | GRB2 (0.86) | GRB2MAPTRECQLSMN1; SMN2ABCB11 | |
| SCHEMBL29352655 | 1.00 | GRB2 (0.86) | GRB2MAPTRECQLSMN1; SMN2ABCB11 | |
| Dactinomycin SCHEMBL6939686 | 0.93 | GRB2 (1.00) | GRB2MAPTRECQLSMN1; SMN2ABCB11 | |
| Dactinomycin SCHEMBL3845 | 0.93 | GRB2 (1.00) | GRB2MAPTRECQLSMN1; SMN2ABCB11 | |
| Dactinomycin SCHEMBL13659669 | 0.93 | GRB2 (1.00) | GRB2MAPTRECQLSMN1; SMN2ABCB11 | |
| Dactinomycin SCHEMBL19770615 | 0.93 | GRB2 (1.00) | GRB2MAPTRECQLSMN1; SMN2ABCB11 | |
| Dactinomycin SCHEMBL6152 | 0.93 | GRB2 (1.00) | GRB2MAPTRECQLSMN1; SMN2ABCB11 | |
| Dactinomycin SCHEMBL3844 | 0.93 | GRB2 (1.00) | GRB2MAPTRECQLSMN1; SMN2ABCB11 | |
| Dactinomycin SCHEMBL27304406 | 0.93 | GRB2 (1.00) | GRB2MAPTRECQLSMN1; SMN2ABCB11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1806 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260117275-A1 | METHODS FOR QUANTITATING VIRAL CAPSIDS | SARTORIUS BIOANALYTICAL INSTRUMENTS, INC. (US) | 2026-04-30 | — | — | US | claimed |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| US-12545905-B2 | Compositions and methods for nucleic acid capture by chemical bait | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2026-02-10 | — | — | US | claimed |
| EP-4642484-A1 | TARGETED TREATMENT OF PROSTATE CANCERS AND OTHER TUMORS BY AN ANTIBODY-DRUG CONJUGATE | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | claimed |
| EP-4642492-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE FUNCTIONAL SMALL MOLECULE COMPOUNDS FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | claimed |
| EP-4176265-B1 | KITS AND METHODS FOR THE ENRICHMENT AND DETECTION OF RNA VIRUSES OF THE CORONAVIRIDAE FAMILY | UNIV MAINZ JOHANNES GUTENBERG (DE) | 2025-08-13 | — | — | EP | claimed |
| US-12332241-B2 | Apoptotic cell mimic | SLINGSHOT BIOSCIENCES, INC. (US) | 2025-06-17 | — | — | US | claimed |
| EP-3864140-B1 | ANALYSIS OF VIABLE AND NONVIABLE CELLS | SAGEMEDIC CORP (US) | 2025-05-21 | — | — | EP | claimed |
| CN-119924112-A | Agricultural greenhouse and manufacturing method thereof | 深圳现象光伏科技有限公司 | 2025-05-06 | — | — | CN | claimed |
| EP-4531813-A1 | APOPTOTIC CELL MIMIC | Slingshot Biosciences, Inc. (US) | 2025-04-09 | — | — | EP | claimed |
| US-20230010108-A1 | A CONJUGATION LINKER CONTAINING 2,3-DIAMINOSUCCINYL GROUP | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2023-01-12 | — | — | US | claimed |
| WO-2022078524-A4 | SPECIFIC CONJUGATION OF AN ANTIBODY | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2022-12-08 | — | — | WO | claimed |
| US-20220378951-A1 | SPECIFIC CONJUGATION LINKERS, SPECIFIC IMMUNOCONJUGATES THEREOF, METHODS OF MAKING AND USES SUCH CONJUGATES THEREOF | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2022-12-01 | — | — | US | claimed |
| US-20220313836-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2022-10-06 | — | — | US | claimed |
| CN-114459982-A | Urine visible component analysis method based on flow cytometry principle | 桂林优利特医疗电子有限公司 | 2022-05-10 | — | — | CN | claimed |
| US-20220119798-A1 | COMPOSITIONS AND METHODS FOR NUCLEIC ACID CAPTURE BY CHEMICAL BAIT | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2022-04-21 | — | — | US | claimed |
| WO-2022078524-A2 | SPECIFIC CONJUGATION OF AN ANTIBODY | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2022-04-21 | — | — | WO | claimed |
| CN-114045263-A | Method for accurately separating KISS1 neurons of rat | 上海昆盟生物科技有限公司 | 2022-02-15 | — | — | CN | claimed |
| US-20120100532-A1 | METHOD FOR IMAGING AND DIFFERENTIAL ANALYSIS OF CELLS | AMNIS CORPORATION (US) | 2012-04-26 | — | — | US | claimed |
| EP-1979000-B1 | METHOD FOR DETECTION OF CANCER CELLS USING VIRUS | SLOAN KETTERING INST CANCER (US) | 2011-07-13 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230010108-A1 | A CONJUGATION LINKER CONTAINING 2,3-DIAMINOSUCCINYL GROUP | DAO, DDO, DCLRE1A | GRB2 1120/4885MAPT 2442/4885RECQL 3836/4885 |
| US-12545905-B2 | Compositions and methods for nucleic acid capture by chemical bait | ANXA5, ANXA2, DNASE1 | GRB2 1529/4885MAPT 4371/4885RECQL 598/4885 |
| US-20220313836-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | CD2BP2, DCLRE1A, EPCAM | GRB2 810/4885MAPT 3017/4885RECQL 4762/4885 |
| US-20220378951-A1 | SPECIFIC CONJUGATION LINKERS, SPECIFIC IMMUNOCONJUGATES THEREOF, METHODS OF MAKING AND USES SUCH CONJUGATES THEREOF | SLC25A1, GCDH, FH | GRB2 2136/4885MAPT 2725/4885RECQL 3695/4885 |
| US-20260117275-A1 | METHODS FOR QUANTITATING VIRAL CAPSIDS | BRI3BP, PRNP, POLL | GRB2 766/4885MAPT 793/4885RECQL 976/4885 |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | DCLRE1A, CCR3, CCR8 | GRB2 455/4885MAPT 4363/4885RECQL 4397/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.